Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$1.07 - $1.55 $20,002 - $28,975
18,694 New
18,694 $24,000
Q3 2020

Nov 02, 2020

SELL
$14.71 - $50.69 $485 - $1,672
-33 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$13.9 - $24.6 $458 - $811
33 New
33 $0

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.